Movella and DIERS Announce 'Free2Move' Healthcare Technology for Objective Patient Assessment
- None.
- None.
Insights
The strategic partnership between Movella Holdings Inc. and DIERS represents a significant development in the field of medical technology and biomechanics. By integrating Movella's advanced motion capture technology with DIERS' medical expertise and DICAM software, the free²move healthcare technology aims to enhance patient assessments in clinical settings. This integration is particularly relevant for stakeholders in the medical device sector, as it aligns with the increasing demand for digital health solutions and precision medicine.
The synergy of Movella's sensor technology with DIERS' validated testing protocols could lead to improved patient outcomes and more efficient healthcare delivery. The adherence to Medical Device Regulation (MDR) and FDA listing indicates a commitment to compliance and quality, which is critical for gaining trust among healthcare providers and patients. The potential impact on the market includes an increased adoption rate of such technologies in rehabilitation and orthopedics, potentially leading to growth opportunities for both companies.
The partnership's focus on creating a healthcare technology that meets rigorous industry standards and regulatory requirements reflects an understanding of the critical nature of accuracy and reliability in patient care. The free²move technology's potential for seamless integration into clinical workflows could disrupt traditional healthcare testing methods, offering a more objective and nuanced approach to patient assessment. This could lead to a shift in how healthcare providers evaluate and track patient progress, with implications for the standard of care and the overall efficiency of healthcare services.
Furthermore, the collaboration is poised to address a gap in the current healthcare market, where there is a need for technologies that can provide high-accuracy data outside of laboratory settings. This could catalyze a broader trend of incorporating motion capture and analysis technologies in various medical applications, thereby expanding the market for both Movella and DIERS.
Given the context of an aging global population and a rise in chronic health conditions, the demand for advanced rehabilitation and diagnostic tools is expected to grow. The integration of Movella's motion capture technology with DIERS' expertise could position the partnership favorably within this expanding market. By offering a product that promises to redefine healthcare testing with certified protocols and unparalleled accuracy, Movella and DIERS may capture a significant market share in the biomechanics and medical device industry.
It is important to note the potential challenges, such as the adoption curve among healthcare professionals and the integration with existing healthcare systems. Nonetheless, the partnership's commitment to regulatory compliance and the emphasis on objective data suggest a strategic approach to overcoming these hurdles and capitalizing on the growing digital health trend.
Strategic Partnership Integrates Xsens Motion Capture and DIERS DICAM Software to Redefine Healthcare Testing with Certified Protocols and Unparalleled Accuracy
Movella and DIERS have joined forces to revolutionize healthcare testing, offering certified protocols and unmatched accuracy. (Photo: Business Wire)
DIERS free²move merges Movella's advanced motion capture technology with DIERS' medical expertise. Central to free²move is the inclusion of the DIERS DICAM software, featuring a range of validated testing protocols. It fulfills and complies with medical requirements of health authorities (Medical Device Regulation-(MDR)) and is also listed with the Food and Drug Administration(FDA). Noteworthy for its emphasis on objective testing, diagnosis, and adherence to treatment protocols, DIERSfree²move introduces a nuanced approach to healthcare technology, prioritizing accuracy and reliability in patient assessment and care.
With more than three decades of experience, DIERS is recognized for its contributions in medical biomechanics, particularly in spine and surface topography analysis. Their expertise extends to various medical applications, including posture analysis and biomechanics in sports.
Carsten Diers, CEO of DIERS International GmbH, said, "Our role is to support professionals in biomechanics and medical biomechanics. With a medical device approved for European and US & Canadian markets, (ISO 13485, EU 2017/745, FDA, CSA), this partnership marks a significant milestone. We can now combine the best in cutting-edge sensor technology with medical knowledge, Reference data and medical guidelines.”
Movella's inertial motion capture solutions, widely utilized in diverse sectors such as health, sports, animation, and robotics, will now be seamlessly integrated into DIERS' comprehensive offerings. The collaboration marks a significant milestone, particularly in the healthcare domain, where the incorporation of Movella's technology is set to revolutionize the practices of orthopedic surgeons, physiotherapists, and rehabilitation centers.
Niek Hollak, Director of Business Partnerships, Movella, said, "We believe in the transformative potential of high-accuracy motion capture in advancing human movement measurement in healthcare and rehabilitation. Through our partnership with DIERS, we unite our state-of-the-art technology with their profound medical expertise, with the shared goal of reshaping rehabilitation practices and enabling healthcare professionals to achieve improved results in a real-world context.”
Movella Holdings Inc. and DIERS remain dedicated to advancing healthcare and biomechanics through this partnership, leveraging technology and medical insights to improve human well-being.
About Movella
Movella is a leading full-stack provider of sensors, software, and AI analytics that turn motion data into lifelike animations and actionable insights. Our motion-tracking technology enables a wide array of innovative solutions in end markets including entertainment and gaming, health and sports, and automation and mobility. We bring meaning to movement for some of the most esteemed global brands including Electronic Arts, EPIC Games, 20th Century Studios, Netflix, BMW, Toyota, and Siemens. For more details, visit www.movella.com
About DIERS
Since its establishment in 1996, DIERS International GmbH has been the pioneer in radiation-free 3D and 4D biomechanical analysis, leading the market through groundbreaking innovations. In partnership with top academic institutions, DIERS has delivered a level of technology that allows healthcare professionals—including orthopedists, physiotherapists, and sports medicine experts—to gain unparalleled insights into the human body's function and form.
Embodying a synergy of cutting-edge science and practical application, DIERS has crafted a suite of products that elegantly fuse functionality with user-centric design, making it the go-to for comprehensive, non-invasive posture and biomechanics analysis. With its global leadership in optical 3D/4D postural and motion analysis, DIERS provides not just measurements, but also meaningful therapy recommendations, enhancing patient care across various medical fields. DIERS is encouraging a more informed and comprehensive approach to biomechanics; to learn more, please visit www.diers.eu
View source version on businesswire.com: https://www.businesswire.com/news/home/20240220855658/en/
Media Contacts
Amitabh Sharan for Movella: amitabh.sharan@movella.com
Antonio Capuano for DIERS: capuano@diers.de
Source: Movella Holdings Inc.
FAQ
What is the name of the healthcare technology introduced by Movella Holdings Inc. and DIERS?
What is the ticker symbol for Movella Holdings Inc.?
What is the main focus of the partnership between Movella Holdings Inc. and DIERS?
Which software is included in the DIERS free²move healthcare technology?
What industry standards does the solution provided by Movella and DIERS meet?
